GlassScriptPhysician profile
Eric L Ellis
NPI 1215968409
$655.44
in general payments reported to CMS, 2019-2025
12 companies · $59.07 in 2025
The $59.07 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.72 · 2021: $58.57 · 2022: $85.71 · 2023: $419 · 2024: $19.27 · 2025: $59.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mckesson Medical-Surgical, INC. | $287.06 | 2023 | |
| Galderma Laboratories, L.P. | $88.28 | 2023 | |
| Abbott Laboratories | $53.13 | 2023-2025 | Id Now Instrument, Proclaim |
| Talis Biomedical Corporation | $52.95 | 2022 | |
| Quidel Corporation | $32.76 | 2022 | |
| Abbvie INC. | $29.06 | 2023 | |
| Pfizer INC. | $20.64 | 2025 | |
| Ptc Therapeutics, INC. | $20.00 | 2021 | |
| Hologic Sales and Service, LLC | $19.81 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $19.27 | 2024 | Airsupra |
| Genentech USA, INC. | $18.76 | 2021 | |
| Lilly USA, LLC | $13.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.